Knockout of TGF-β type II receptor (TβRII) in Nes+ MSCs reduced osteoarthritis development after ACLT surgery compared with sham-operated mice, which confirmed that Nes+ MSCs were the target cell population of TGF-β signaling. This evidence concerns the gene NES and osteoarthritis.